DIC resident survival guide: Difference between revisions
Jump to navigation
Jump to search
Ochuko Ajari (talk | contribs) |
|||
Line 29: | Line 29: | ||
==Management== | ==Management== | ||
{{familytree/start}} | |||
{{familytree | | | | | | | | | | | A01 | | | | |A01=}} | |||
{{familytree | | | | | | |,|-|-|-|-|^|-|-|.| | |}} | |||
{{familytree | | | | | | B01 | | | | | | B02 | |B01=|B02=}} | |||
{{familytree | | |,|-|-|-|+|-|-|-|.| | | |!| | | |}} | |||
{{familytree | | C01 | | C02 | | C03 | | C04 | | | | |C01=|C02=|C03=|C04=}} | |||
{{familytree | | | | | | | | | | | | | | |!| | | |}} | |||
{{familytree | | | | | | | | | | | | | | D01 | | | |D01=}} | |||
{{familytree | | | | | | | | | | | |,|-|-|^|-|-|.| | |}} | |||
{{familytree | | | | | | | | | | | E01 | | | | E02 | | |E01=|E02=}} | |||
{{familytree | | | | | | | | | |,|-|^|-|.| | | |!| | |}} | |||
{{familytree | | | | | | | | | F01 | | F02 | | F03 | | |F01=|F02=|F03=}} | |||
{{familytree | | | | | | | | | | | | | | | |,|-|^|-|.| |}} | |||
{{familytree | | | | | | | | | | | | | | | G01 | | G02 | |G01=|G02=}} | |||
{{familytree | | | | | | | | | | | | | |,|-|^|-|.| | |}} | |||
{{familytree | | | | | | | | | | | | | H01 | | H02 | |H01=|H02=}} | |||
{{familytree/end}} | |||
==Do's== | ==Do's== |
Revision as of 21:12, 24 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2]
Overview
Disseminated intravascular coagulation, is a pathological process in the body where the blood starts to coagulate throughout the whole body. This depletes the body of its platelets and coagulation factors, and there is a paradoxically increased risk of hemorrhage.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Disseminated intravascular coagulation in itself is a life-threatening condition and must be treated as such irrespective of the causes.
Common Causes
- Abruptio placentae
- Amniotic fluid embolism
- Aortic aneurysm
- Drugs (e.g. Amphetamines)
- Eclampsia
- Giant hemangioma
- HELLP syndrome
- Hemolytic transfusion reaction
- Malignancy (especially APL)
- Sepsis
- Severe allergic reaction
- Transplant rejection
- Trauma (e.g. Fat embolism, head injury)
- Venomous snake
Management
Do's
- The transfusion of platelets should be considered for those patients actively bleeding or at an increased risk of bleeding with a platelet count of less than 50,000 microliter.[1]
- [[Fibrinogen level should be kept at a level greater than 100mg/dl
- Therapy with heparin used generally for patients with low grade DIC having predominantly thrombotic episodes such as acral ischemia and thrombophlebitis.
Dont's
- Do not transfuse platelets or plasma based primarily on laboratory results but should generally be for patients who are bleeding.[1]
- Don't give recombinant human activated protein C to patients with increased risk of bleeding.[1]
- Don't give recombinant human activated protein C to patients with platelet counts < 30,000 microliter.[1]
- Avoid the intravenous bolus injection of heparin of 50,000-10,000 units.
References
- ↑ 1.0 1.1 1.2 1.3 Levi M, Toh CH, Thachil J, Watson HG (2009). "Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology". Br J Haematol. 145 (1): 24–33. doi:10.1111/j.1365-2141.2009.07600.x. PMID 19222477.